Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 3–3 | Cite as

Post-approval studies in US are "vital to enhancing patient safety"

News item
  • 24 Downloads

Reference

  1. Gottlieb S. Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA's efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs. Internet Document : 16 Nov 2018. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626090.htm

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations